These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 25933743)

  • 1. Assessment of the residual tumour of colorectal liver metastases after chemotherapy: diffusion-weighted MR magnetic resonance imaging in the peripheral and entire tumour.
    Wagner M; Ronot M; Doblas S; Giraudeau C; Van Beers B; Belghiti J; Paradis V; Vilgrain V
    Eur Radiol; 2016 Jan; 26(1):206-15. PubMed ID: 25933743
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 3T diffusion-weighted MRI in the response assessment of colorectal liver metastases after chemotherapy: Correlation between ADC value and histological tumour regression grading.
    Donati F; Boraschi P; Pacciardi F; Cervelli R; Castagna M; Urbani L; Falaschi F; Caramella D
    Eur J Radiol; 2017 Jun; 91():57-65. PubMed ID: 28629572
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Liver metastases from colorectal cancer treated with conventional and antiangiogenetic chemotherapy: evaluation with liver computed tomography perfusion and magnetic resonance diffusion-weighted imaging.
    Anzidei M; Napoli A; Zaccagna F; Cartocci G; Saba L; Menichini G; Cavallo Marincola B; Marotta E; Di Mare L; Catalano C; Passariello R
    J Comput Assist Tomogr; 2011; 35(6):690-6. PubMed ID: 22082538
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disappearing or residual tiny (≤5 mm) colorectal liver metastases after chemotherapy on gadoxetic acid-enhanced liver MRI and diffusion-weighted imaging: Is local treatment required?
    Kim SS; Song KD; Kim YK; Kim HC; Huh JW; Park YS; Park JO; Kim ST
    Eur Radiol; 2017 Jul; 27(7):3088-3096. PubMed ID: 27815722
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diffusion-weighted and hepatobiliary phase gadoxetic acid-enhanced quantitative MR imaging for identification of complete pathologic response in colorectal liver metastases after preoperative chemotherapy.
    Hosseini-Nik H; Fischer SE; Moulton CA; Karbhase G; Menezes RJ; Gallinger S; Jhaveri KS
    Abdom Radiol (NY); 2016 Feb; 41(2):231-8. PubMed ID: 26867904
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potential of MR histogram analyses for prediction of response to chemotherapy in patients with colorectal hepatic metastases.
    Liang HY; Huang YQ; Yang ZX; Ying-Ding ; Zeng MS; Rao SX
    Eur Radiol; 2016 Jul; 26(7):2009-18. PubMed ID: 26494642
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Baseline 3D-ADC outperforms 2D-ADC in predicting response to treatment in patients with colorectal liver metastases.
    Fouladi DF; Zarghampour M; Pandey P; Pandey A; Varzaneh FN; Ghasabeh MA; Khoshpouri P; Kamel IR
    Eur Radiol; 2020 Jan; 30(1):291-300. PubMed ID: 31209620
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diffusion-weighted imaging and loco-regional N staging of patients with colorectal liver metastases.
    Bonifacio C; Viganò L; Felisaz P; Lopci E; Cimino M; Poretti D; Donadon M; Pedicini V; Procopio F; Chiti A; Balzarini L; Torzilli G
    Eur J Surg Oncol; 2019 Mar; 45(3):347-352. PubMed ID: 30528892
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predicting Treatment Response of Colorectal Cancer Liver Metastases to Conventional Lipiodol-Based Transarterial Chemoembolization Using Diffusion-Weighted MR Imaging: Value of Pretreatment Apparent Diffusion Coefficients (ADC) and ADC Changes Under Therapy.
    Lahrsow M; Albrecht MH; Bickford MW; Vogl TJ
    Cardiovasc Intervent Radiol; 2017 Jun; 40(6):852-859. PubMed ID: 28357571
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic value of pretreatment diffusion-weighted magnetic resonance imaging for outcome prediction of colorectal cancer liver metastases undergoing 90Y-microsphere radioembolization.
    Schmeel FC; Simon B; Luetkens JA; Träber F; Meyer C; Schmeel LC; Sabet A; Ezziddin S; Schild HH; Hadizadeh DR
    J Cancer Res Clin Oncol; 2017 Aug; 143(8):1531-1541. PubMed ID: 28317063
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic value of ADC measurements in predicting overall survival in patients undergoing
    Alis D; Durmaz ESM; Gulsen F; Bas A; Kabasakal L; Sager S; Numan F
    Clin Imaging; 2019; 57():124-130. PubMed ID: 31220677
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diffusion-weighted magnetic resonance imaging predicts survival in patients with liver-predominant metastatic colorectal cancer shortly after selective internal radiation therapy.
    Schmeel FC; Simon B; Sabet A; Luetkens JA; Träber F; Schmeel LC; Ezziddin S; Schild HH; Hadizadeh DR
    Eur Radiol; 2017 Mar; 27(3):966-975. PubMed ID: 27271923
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Whole-liver diffusion-weighted MRI histogram analysis: effect of the presence of colorectal hepatic metastases on the remaining liver parenchyma.
    Lambregts DM; Martens MH; Quah RC; Nikiforaki K; Heijnen LA; Dejong CH; Beets GL; Marias K; Papanikolaou N; Beets-Tan RG
    Eur J Gastroenterol Hepatol; 2015 Apr; 27(4):399-404. PubMed ID: 25874512
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Equivalent cross-relaxation rate imaging and diffusion weighted imaging for early prediction of response to bevacizumab-containing treatment in colorectal liver metastases-preliminary study.
    Matsushima S; Sato T; Nishiofuku H; Sato Y; Murata S; Kinosada Y; Era S; Inaba Y
    Clin Imaging; 2017; 41():1-6. PubMed ID: 27721090
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intravoxel incoherent motion diffusion-weighted magnetic resonance imaging for predicting histological grade of hepatocellular carcinoma: Comparison with conventional diffusion-weighted imaging.
    Zhu SC; Liu YH; Wei Y; Li LL; Dou SW; Sun TY; Shi DP
    World J Gastroenterol; 2018 Feb; 24(8):929-940. PubMed ID: 29491686
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early detection of therapeutic response to hepatic arterial infusion chemotherapy of liver metastases from colorectal cancer using diffusion-weighted MR imaging.
    Marugami N; Tanaka T; Kitano S; Hirohashi S; Nishiofuku H; Takahashi A; Sakaguchi H; Matsuoka M; Otsuji T; Takahama J; Higashiura W; Kichikawa K
    Cardiovasc Intervent Radiol; 2009 Jul; 32(4):638-46. PubMed ID: 19238482
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of pre-treatment diffusion-weighted MRI in predicting long-term outcome of colorectal liver metastasis.
    Tam HH; Collins DJ; Brown G; Chau I; Cunningham D; Leach MO; Koh DM
    Br J Radiol; 2013 Oct; 86(1030):20130281. PubMed ID: 23995873
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Value of diffusion weighted MR imaging as an early surrogate parameter for evaluation of tumor response to high-dose-rate brachytherapy of colorectal liver metastases.
    Wybranski C; Zeile M; Löwenthal D; Fischbach F; Pech M; Röhl FW; Gademann G; Ricke J; Dudeck O
    Radiat Oncol; 2011 Apr; 6(1):43. PubMed ID: 21524305
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection and Viability of Colorectal Liver Metastases After Neoadjuvant Chemotherapy: A Multiparametric PET/CT-MRI Study.
    Dunet V; Halkic N; Prior JO; Anaye A; Meuli RA; Sempoux C; Denys A; Schmidt S
    Clin Nucl Med; 2017 Apr; 42(4):258-263. PubMed ID: 28166142
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diffusion weighted imaging of liver lesions suspect for metastases: Apparent diffusion coefficient (ADC) values and lesion contrast are independent from Gd-EOB-DTPA administration.
    Benndorf M; Schelhorn J; Dietzel M; Kaiser WA; Baltzer PA
    Eur J Radiol; 2012 Aug; 81(8):e849-53. PubMed ID: 22575171
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.